Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
H Pfeiffer-Vornkahl
Observed names:
H. Pfeiffer-Vornkahl,
H. Pfeiffer‐Vornkahl,
Heike Pfeiffer-Vornkahl,
Heike Pfeiffer‐Vornkahl,
Heike-Pfeiffer Vornkahl,
Pfeiffer-Vornkahl, Heike
show all 6
OpenAlex ID:
A5084459140
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C
2017
·
Peter Buggisch
, Johannes Vermehren
, et al.
·
Journal of Hepatology
·
74
Real‐world use, effectiveness and safety of anti‐viral treatment in chronic hepatitis C genotype 3 infection
2017
·
M. Cornberg
, J. Petersen
, et al.
·
Alimentary Pharmacology & Therapeutics
·
50
Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials
2016
·
Frank Tacke
, Rainer Günther
, et al.
·
Liver International
·
50
Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real‐world setting
2017
·
Christoph Höner zu Siederdissen
, Peter Buggisch
, et al.
·
United European Gastroenterology Journal
·
33
Treatment Results of Chronic Hepatitis C Genotype 5 and 6 Infections in Germany
2012
·
S. Mauss
, F. Berger
, et al.
·
Zeitschrift für Gastroenterologie
·
30
Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcome
2012
·
S. Mauss
, F. Berger
, et al.
·
Journal of Viral Hepatitis
·
24
Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral treatment
2018
·
Viola Knop
, Wolf P. Hofmann
, et al.
·
Journal of Viral Hepatitis
·
20
Real-life experience with first generation HCV protease inhibitor therapy in Germany: The prospective, non-interventional PAN cohort
2015
·
S. Mauss
, K. Böker
, et al.
·
Zeitschrift für Gastroenterologie
·
15
Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors – Results from the PAN Study
2016
·
Jona T. Stahmeyer
, Siegbert Rossol
, et al.
·
PLoS ONE
·
14
Costs and outcomes of treating chronic hepatitis C patients in routine care – results from a nationwide multicenter trial
2015
·
J. T. Stahmeyer
, C. Krauth
, et al.
·
Journal of Viral Hepatitis
·
13
Treatment Outcomes for Hepatitis C Genotype 1 Infection with Direct Acting Antivirals: Data from the German Hepatitis C-Registry
2016
·
S. Mauss
, P. Buggisch
, et al.
·
Journal of Hepatology
·
9
Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study
2015
·
Wolf Peter Hofmann
, Stefan Mauss
, et al.
·
PLoS ONE
·
9
PDF
Long‐term outcome of chronic hepatitis C virus infection in a real‐world setting: The German LOTOS study
2017
·
Heiner Wedemeyer
, Jens Reimer
, et al.
·
Liver International
·
8
Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1
2016
·
Tim Zimmermann
, Dietrich Hueppe
, et al.
·
Journal of Gastrointestinal and Liver Diseases
·
6
Long-term follow-up after IFN-free therapy of advanced HCV-associated liver cirrhosis: continued improvement of liver function parameters – Results from the German Hepatitis C-Registry (DHC-R)
2017
·
K. Deterding
, S. Mauss
, et al.
·
Journal of Hepatology
·
4
Treatment of HCV Genotype 2 with Sofosbuvir and Ribavirin Results in Low SVR Rates ina Real World Cohort (German Hepatitis C-Registry, DHC-R)
2016
·
F. Tacke
, R. Günther
, et al.
·
Journal of Hepatology
·
3
Safety and Efficacy of IFN- Free Antiviral Therapies in Advanced HCV- Associated Liver Cirrhosis: Results from the German Hepatitis C-Registry (DHC-R)
2016
·
K. Deterding
, P. Buggisch
, et al.
·
Journal of Hepatology
·
2
P1147 Outcomes and Costs of Treating Hepatitis C With Protease Inhibitors: Results From a Multi-centre Study
2014
·
J.T. Stahmeyer
, S. Rossol
, et al.
·
Journal of Hepatology
·
2
Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial
2013
·
J.T. Stahmeyer
, S. Rossol
, et al.
·
Value in Health
·
2
Treatment of Patients with Hepatitis C Virus (HCV) Genotype 3 Infection in the Era of Direct Acting Antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R)
2016
·
M. Cornberg
, P. Buggisch
, et al.
·
Journal of Hepatology
·
1
Therapieanpassung von Biologika bei mittelschwerer bis schwerer Plaque‐Psoriasis: eine retrospektive Erhebung aus deutschen Krankenakten (TABU)
2024
·
Natalia Kirsten
, Simone Rubant
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
PDF
Treatment adjustment in biologic therapies for moderate‐to‐severe plaque psoriasis: a German retrospective chart review (TABU)
2024
·
Natalia Kirsten
, Simone Rubant
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
PDF
Entwicklung des Krankheitsbildes und der Behandlung von Patienten mit chronischer Hepatitis C-Infektion (HCV) unter Real-World Bedingungen in Deutschland: Erfahrungen aus 14 Jahren mit mehr als 16.000 Patienten
2017
·
D Hüppe
, P Buggisch
, et al.
·
Zeitschrift für Gastroenterologie
Langzeitnachbeobachtung nach IFN-freier Therapie bei fortgeschrittener HCV-assoziierter Leberzirrhose: Kontinuierliche Verbesserung der Leberfunktionsparameter – Ergebnisse aus dem Deutschen Hepatitis C-Register (DHC-R)
2017
·
K Deterding
, S Mauss
, et al.
·
Zeitschrift für Gastroenterologie
Effektivität der Therapie bei Leberzirrhose und chronischer Hepatitis C Genotyp 1 Virusinfektion – Resultate aus dem Deutschen Hepatitis C-Register
2017
·
C Höner zu Siederdissen
, P Buggisch
, et al.
·
Zeitschrift für Gastroenterologie
Show more works
View as search
Works count:
39
Citation count:
369
H-index:
10
I10-index:
10
Year
Topic
Type